Samira CP, Andrisa RS. Efficacy and Safety of Imiquimod 5% as Primary Therapy in Management of Nodular Basal Cell Carcinoma of the Eyelid. OI [Internet]. 2017 Feb. 9 [cited 2025 Oct. 5];42(2). Available from: https://www.ophthalmologica-indonesiana.com/index.php/journal/article/view/80